Online Pharmacy, Tramadol, Paxil, antibiotics, amoxicillin, zithromax, Rx Online, pharmaceuticals, DHEA, prescription medications, prescription drugs.

Drugs online research references

Am Fam Physician. 2002 Mar 15;65(6):1138-42.
Neonatal herpes simplex virus infections.

Rudnick CM, Hoekzema GS.

St. Anthony's Medical Center, St. Louis, Missouri, USA.

Neonatal herpes simplex virus infections can result in serious morbidity and mortality. Many of the infections result from asymptomatic cervical shedding of virus after a primary episode of genital HSV in the third trimester. Antibodies to HSV-2 have been detected in approximately 20 percent of pregnant women, but only 5 percent report a history of symptomatic infection. All primary episodes of HSV and secondary episodes near term or at the time of delivery should be treated with antiviral therapy. If active HSV infection is present at the time of delivery, cesarean section should be performed. Symptomatic and asymptomatic primary genital HSV infections are associated with preterm labor and low-birth-weight infants. The diagnosis of neonatal HSV can be difficult, but it should be suspected in any newborn with irritability, lethargy, fever or poor feeding at one week of age. Diagnosis is made by culturing the blood, cerebrospinal fluid, urine and fluid from eyes, nose and mucous membranes. All newborns suspected to have or who are diagnosed with HSV infection should be treated with parenteral acyclovir.

online pharmacy ref source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11925091&dopt=Abstract

Cas Lek Cesk. 1996 Apr 17;135(8):244-8.
[Changes in the incidence and clinical manifestations of herpes zoster]

[Article in Czech]

Cerny Z.

Infekcni klinika LF MU, Brno.

BACKGROUND: Shingles is the manifestation of activated latent disease caused by the varicella-herpes zoster virus. The prerequisite of its activation is a reduction of the immunity of the organism: the incidence (with some reservations) of herpes zoster in the population can be therefore considered an indicator of the general immune state. The objective of the submitted paper was to assess whether and to what extent the frequency of herpes zoster increased (whether the number of patients hospitalized at the Clinic for Infectious Diseases increased in 1974-1994, and if so, by how much). METHODS AND RESULTS: By comparing clinical manifestations of herpes zoster in a group of 348 patients hospitalized in 1992-1994 with results of a similar investigation made in the same department in a group of 308 patients hospitalized in 1979-1983 the following was revealed: the annual numbers of treated patients with herpes zoster doubled during the last 15 years. Almost 70% of the affected patients were then and now above 60 years of age, among the patients women predominated markedly (chi 2 = 69.540), the number of malignancies increased greatly (chi 2 = 4.435), there was also a significant increase of ischaemic heart disease, hypertension (chi 2 = 39.741) etc. As to the ratio of different sites of the shingles, no significant changes were observed, while there was a significant increase of manifestations of dermal generalization (chi 2 = 36.377) and a significant increase of peripheral pareses (chi 2 = 5.615). The author explains the fact that the period of hospitalization was not longer and that there was even a significant decrease in the number of postherpetic neuralgias persisting for more than a month, by the early onset of treatment with acyclovir administered by the i.v. route. CONCLUSIONS: The annual numbers of patients hospitalized on account of herpes zoster doubled during the past 15 years, the number of malignancies increased as well as the number of cardiovascular diseases, and the frequency of skin generalizations and peripheral pareses increased. Treatment with acyclovir had a favourable effect on the period of hospitalization.

online pharmacy ref source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8689663&dopt=Abstract

aurorabio.com

Herpes simplex virus infections are the cause of significant morbidity, and currently used therapeutics are largely based on modified nucleoside analogs that inhibit viral DNA polymerase function. To target this disease in a new way, we have identified and optimized selective thiazolylphenyl-containing inhibitors of the herpes simplex virus (HSV) helicase-primase enzyme. The most potent compounds inhibited the helicase, the primase and the DNA-dependent ATPase activities of the enzyme with IC50 (50% inhibitory concentration) values less than 100 nM. Inhibition of the enzymatic activities was through stabilization of the interaction between the helicase-primase and DNA substrates, preventing the progression through helicase or primase catalytic cycles. Helicase-primase inhibitors also prevented viral replication as demonstrated in viral growth assays. One compound, BILS 179 BS, displayed an EC50 (effective concentration inhibiting viral growth by 50%) of 27 nM against viral growth with a selectivity index greater than 2,000. Antiviral activity was also demonstrated for multiple strains of HSV, including strains resistant to nucleoside-based therapies. Most importantly, BILS 179 BS was orally active against HSV infections in murine models of HSV-1 and HSV-2 disease and more effective than acyclovir when the treatment frequency per day was reduced or when initiation of treatment was delayed up to 65 hours after infection. These studies validate the use of helicase-primase inhibitors for the treatment of acute herpesvirus infections and provide new lead compounds for optimization and design of superior anti-HSV agents.

online pharmacy ref source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11927945&dopt=Abstract

online pharmacies || Hair Million herbal formula for hair loss and hair growth || Tramadol || Antibiotics and prescription medications online literature || Antibiotics